期刊
ONCOLOGY RESEARCH
卷 27, 期 3, 页码 379-387出版社
COGNIZANT COMMUNICATION CORP
DOI: 10.3727/096504018X15199531937158
关键词
Long noncoding RNAs (lncRNAs); CASC2; Breast cancer; Transforming growth factor-beta (TGF-beta)
类别
资金
- National Natural Science Foundation of China [81870977]
- Scientific Research Foundation of Heilongjiang Province [LC2017040]
Breast cancer is one of the major malignancies with a mounting mortality rate in the world. Long noncoding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2) has been identified to regulate the initiation and progression of multiple tumorous diseases according to previous studies. However, its biological role has been rarely reported in breast cancer. In the present study, lncRNA CASC2 was found to be significantly downregulated in breast cancer tissues and cell lines using real-time quantitative PCR. Furthermore, gain-of-function assays demonstrated that overexpression of lncRNA CASC2 significantly repressed breast cancer cell proliferation and metastasis. Moreover, CASC2 induced cell cycle arrest and much more early apoptosis of breast cancer. Additionally, based on the above research, we illustrated that inactivation of the TGF-beta signaling pathway was involved in the function of lncRNA CASC2. Collectively, lncRNA CASC2 was a key factor in the tumorigenesis and malignancy of breast cancer, suggesting it may possibly be a potential therapy target for the treatment of breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据